Correlation Between Biovie and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Biovie and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biovie and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biovie Inc and NewAmsterdam Pharma, you can compare the effects of market volatilities on Biovie and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biovie with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biovie and NewAmsterdam Pharma.
Diversification Opportunities for Biovie and NewAmsterdam Pharma
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Biovie and NewAmsterdam is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Biovie Inc and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Biovie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biovie Inc are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Biovie i.e., Biovie and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Biovie and NewAmsterdam Pharma
Given the investment horizon of 90 days Biovie Inc is expected to under-perform the NewAmsterdam Pharma. In addition to that, Biovie is 2.09 times more volatile than NewAmsterdam Pharma. It trades about -0.02 of its total potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.06 per unit of volatility. If you would invest 894.00 in NewAmsterdam Pharma on August 29, 2024 and sell it today you would earn a total of 1,190 from holding NewAmsterdam Pharma or generate 133.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biovie Inc vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Biovie Inc |
| NewAmsterdam Pharma |
Biovie and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biovie and NewAmsterdam Pharma
The main advantage of trading using opposite Biovie and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biovie position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.| Biovie vs. Eliem Therapeutics | Biovie vs. Scpharmaceuticals | Biovie vs. Milestone Pharmaceuticals | Biovie vs. Seres Therapeutics |
| NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. Scpharmaceuticals | NewAmsterdam Pharma vs. Milestone Pharmaceuticals | NewAmsterdam Pharma vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |